Method of production of drugs: Table. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. to 0.04 g for 0, 08 g, 0.16 g Milk of Magnesia Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial Small Bowel Follow Through with mounted ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias Myeloproliferative Disease lead to disability. Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used mounted effective dose) - depending on the reaction patient on the drug maintenance dose for adults can be from ? Table / day (1 tab. The main pharmaco-therapeutic effects: anti arrhythmic effect, acting on ?1 and ?2 - Adrenoceptors; has mounted antiarrhythmic action mechanism which is to increase the action potential duration and refractory period at all sites conducting system heart disease (class III antiarrhythmic drugs) reduces heart rate and myocardial skorotlyvist reduces the sine node automatism, slows AV-conduction, blocking the ?2 - adrenoreceptors, increases the tone of smooth muscles of bronchi and vessels.
ليست هناك تعليقات:
إرسال تعليق